Key Takeaways A significant portion of younger workers are sceptical that traditional full-time employment can provide long-term financial security, driving a shift towards alternative income sources like the gig economy....
Key Takeaways Genius Group has executed a repurchase of one million shares, advancing a broader mandate to buy back up to 20% of its outstanding stock. This move reduces the...
Key Takeaways The prospect of Ethereum surpassing the $4,000 resistance level is creating significant interest in correlated assets like SharpLink Gaming (SBET). SharpLink’s substantial Ethereum treasury, now exceeding 500,000 ETH,...
Key Takeaways President Trump has called for the immediate resignation of Intel’s CEO, citing alleged conflicts of interest related to China, which introduces significant political risk for the company. The...
Key Takeaways Generation X reports the most significant financial insecurity, caught between the responsibilities of supporting both ageing parents and their children. Stagnant wage growth, multiple economic recessions, and higher...
Key Takeaways A potential US executive order could permit cryptocurrency investments within retirement plans, such as 401(k)s, which collectively hold around $12.5 trillion in assets. Even a modest allocation of...
Key Takeaways Profitability Achieved: Pagaya reported a GAAP net income of $17 million, its second consecutive profitable quarter and a $91 million improvement from the prior year’s loss, signalling a...
Key Takeaways MDA’s order backlog surged to $4.6 billion, providing multi-year revenue visibility and suggesting strong market demand for its satellite and robotics technology. Quarterly revenue increased by 54% year-over-year...
Key Takeaways An anticipated executive order is set to permit alternative assets, such as cryptocurrencies and real estate, within US 401(k) retirement plans. The directive could unlock a portion of...
Key Takeaways Eli Lilly’s oral GLP-1, orforglipron, demonstrated an average weight loss of around 12% in Phase 3 trials, a figure considered statistically significant but below the 15% efficacy whisper...
